Fig. 7From: Apoptotic tumor cell-derived microparticles loading Napabucasin inhibit CSCs and synergistic immune therapyIn vivo evaluation of anti-metastatic liver tumor effect. A The therapeutic schedule. B–E PET/CT imaging and representative mice in the end. F Representative liver and spleen tissues in the end. G The average weight of liver tissues in the end. H The average weight of spleen tissues in the end. I Representative H&E staining images of liver tissues from the euthanized mice. J The tumor area fraction of liver tissuesBack to article page